Capricor Therapeutics
CAPR
#7991
Rank
โ‚ฌ0.24 B
Marketcap
5,44ย โ‚ฌ
Share price
-4.36%
Change (1 day)
-61.47%
Change (1 year)

Market capitalization of Capricor Therapeutics (CAPR)

Market cap: โ‚ฌ0.24 Billion

As of December 2025 Capricor Therapeutics has a market cap of โ‚ฌ0.24 Billion. This makes Capricor Therapeutics the world's 7991th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Capricor Therapeutics from 2002 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ0.24 B-59.58%
2024โ‚ฌ0.61 B351.67%
2023โ‚ฌ0.13 B49.96%
2022โ‚ฌ90.83 M45.38%
2021โ‚ฌ62.47 M9.57%
2020โ‚ฌ57.02 M854.65%
2019โ‚ฌ5.97 M-46.9%
2018โ‚ฌ11.24 M-66.77%
2017โ‚ฌ33.85 M-37.44%
2016โ‚ฌ54.11 M18.43%
2015โ‚ฌ45.69 M26.59%
2014โ‚ฌ36.09 M31.24%
2013โ‚ฌ27.5 M1634.92%
2012โ‚ฌ1.58 M-90.49%
2011โ‚ฌ16.66 M3.24%
2010โ‚ฌ16.14 M-29.44%
2009โ‚ฌ22.87 M55.79%
2008โ‚ฌ14.68 M-83.83%
2007โ‚ฌ90.77 M3866.32%
2006โ‚ฌ2.28 M-44.75%
2005โ‚ฌ4.14 M14.51%
2004โ‚ฌ3.61 M18.29%
2003โ‚ฌ3.05 M-69.75%
2002โ‚ฌ10.11 M

End of Day market cap according to different sources

On Dec 10th, 2025 the market cap of Capricor Therapeutics was reported to be:

โ‚ฌ1.26 Billion
by Nasdaq info icon info icon
โ‚ฌ0.24 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Cytokinetics
CYTK
โ‚ฌ6.30 B 2,436.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
โ‚ฌ37.31 M-85.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ425.61 B 171,037.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚ฌ13.27 B 5,236.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚ฌ1.60 B 544.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚ฌ8.59 M-96.54%๐Ÿ‡บ๐Ÿ‡ธ USA